Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Market open

 --Real time quotes

Jun 9, 2023, 9:45 a.m.

/zigman2/quotes/205619834/composite

$

124.45

Change

-0.49 -0.39%

Volume

Volume 128,393

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 124.94

$ 124.45

Change

-0.49 -0.39%

Day low

Day high

$123.78

$124.92

Open

52 week low

52 week high

$115.03

$217.25

Open

Paul Burton

Presently, Paul Burton holds the position of Chief Medical Officer at Moderna, Inc. and Chief Global Medical Affairs Officer at Janssen Pharmaceuticals, Inc. He is also Member of Royal College of Surgeons.

Dr. Burton previously occupied the position of Vice President for Janssen Research & Development LLC.

Paul Burton received a doctorate from the University of London and a doctorate from Imperial College London.

Transactions

Date Shares Transaction Value
11/07/2022 192   Disposition at $158.68 per share. 30,467
11/04/2022 402   Derivative/Non-derivative trans. at $0 per share. 0
08/08/2022 865   Disposition at $185.1 per share. 160,112
08/05/2022 1,609   Derivative/Non-derivative trans. at $194.18 per share. 312,435

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. James M. Mock
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Dr. Jerh Collins
Chief Technical Operations & Quality Officer
Mr. Brad Miller
Chief Information Officer
Dr. Melanie Ivarsson
Chief Development Officer
Dr. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Jonathan Hoggatt
Director-Hematology
Ms. Arpa Garay
Chief Commercial Officer
Mr. Juan Andres
President-Strategic Partnerships
Ms. Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Paula Hammond
Scientific Advisory Board
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.